Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)

NCT06354660 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

537

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Type 2

Interventions

DRUG: Retatrutide
DRUG: Placebo

Sponsor

Eli Lilly and Company